ROTOFIER Extended-Release Tablets

Indications:  This product is used on the basis of full diet control, for the treatment of hyperglycemia and correlative symptoms of Type-2 diabetes.

Main Ingredient (API):  Glipizide.

Dosages:  5mg X 14/21 tablets.

Status:  Prescription (Rx) drug covered under Class B Central Government Insurance.

Technology:  Utilizes a bi-layer osmotic pump delievery system.